Schiedat, F.; Meuterodt, B.; Winter, J.; Prull, M.; Aweimer, A.; Gotzmann, M.; O’Connor, S.; Perings, C.; Lawo, T.; El-Battrawy, I.;
et al. Subcutaneous versus Transvenous Implantable Cardioverter Defibrillator in Patients with End-Stage Renal Disease Requiring Dialysis: Extended Long-Term Retrospective Multicenter Follow-Up. J. Pers. Med. 2024, 14, 870.
https://doi.org/10.3390/jpm14080870
AMA Style
Schiedat F, Meuterodt B, Winter J, Prull M, Aweimer A, Gotzmann M, O’Connor S, Perings C, Lawo T, El-Battrawy I,
et al. Subcutaneous versus Transvenous Implantable Cardioverter Defibrillator in Patients with End-Stage Renal Disease Requiring Dialysis: Extended Long-Term Retrospective Multicenter Follow-Up. Journal of Personalized Medicine. 2024; 14(8):870.
https://doi.org/10.3390/jpm14080870
Chicago/Turabian Style
Schiedat, Fabian, Benjamin Meuterodt, Joachim Winter, Magnus Prull, Assem Aweimer, Michael Gotzmann, Stephen O’Connor, Christian Perings, Thomas Lawo, Ibrahim El-Battrawy,
and et al. 2024. "Subcutaneous versus Transvenous Implantable Cardioverter Defibrillator in Patients with End-Stage Renal Disease Requiring Dialysis: Extended Long-Term Retrospective Multicenter Follow-Up" Journal of Personalized Medicine 14, no. 8: 870.
https://doi.org/10.3390/jpm14080870
APA Style
Schiedat, F., Meuterodt, B., Winter, J., Prull, M., Aweimer, A., Gotzmann, M., O’Connor, S., Perings, C., Lawo, T., El-Battrawy, I., Hanefeld, C., Korth, J., Mügge, A., & Kloppe, A.
(2024). Subcutaneous versus Transvenous Implantable Cardioverter Defibrillator in Patients with End-Stage Renal Disease Requiring Dialysis: Extended Long-Term Retrospective Multicenter Follow-Up. Journal of Personalized Medicine, 14(8), 870.
https://doi.org/10.3390/jpm14080870
